Crohns Disease: Clinical Trials

3 trials for Crohns Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Not yet recruiting 1, Terminated 1

Follow Crohns Disease: new trials by email Literature Review of Crohns Disease trials Research Report on Crohns Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis
Mirikizumab - Crohn Disease (CD), Crohns Disease
Phase 4Not yet recruitingRubix LS1502025-07-162025-07-10
Pneumococcal Vaccination of Crohn Patients
Prevenar 13, Pneumovax - Crohns Disease
Phase 4CompletedStatens Serum Institut1512013-07-012015-02-10
Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease
Colesevelam, Placebo - Crohns Disease, Bile Acid Malabsorption
Phase 4TerminatedFlorian Beigel342010-10-012013-04-18

Narrower conditions

Crohn Disease (3)  ·  Colitis, Ulcerative (1)

Broader conditions

Digestive System Diseases (3)  ·  Gastroenteritis (3)  ·  Gastrointestinal Diseases (3)  ·  Inflammatory Bowel Diseases (3)  ·  Intestinal Diseases (3)  ·  Colitis (1)  ·  Colonic Diseases (1)

Interventions

13-valent pneumococcal vaccine (1)  ·  Colesevelam Hydrochloride (1)  ·  Pneumococcal Vaccines (1)  ·  mirikizumab (1)

Sponsors

Florian Beigel (1)  ·  Rubix LS (1)  ·  Statens Serum Institut (1)

Countries

Denmark (1)  ·  Germany (1)  ·  United States (1)

Top investigators

Andreas M Petersen, MD (1)  ·  Florian Beigel, M.D. (1)

Results publications

PMID 24953836, PMID 26275480, PMID 31290715

NIH funding

2009 (1)